GM23671
LCL from B-Lymphocyte
Description:
ORNITHINE TRANSCARBAMYLASE DEFICIENCY, HYPERAMMONEMIA DUE TO; OTC
ORNITHINE CARBAMOYLTRANSFERASE; OTC
Repository
|
NIGMS Human Genetic Cell Repository
|
Subcollection |
Heritable Diseases Disorders of the Urea Cycle |
Biopsy Source
|
Peripheral vein
|
Cell Type
|
B-Lymphocyte
|
Tissue Type
|
Blood
|
Transformant
|
Epstein-Barr Virus
|
Sample Source
|
LCL from B-Lymphocyte
|
Race
|
More than one race
|
Ethnicity
|
CAUCASIAN/ASIAN
|
Family History
|
N
|
Relation to Proband
|
proband
|
Confirmation
|
Molecular characterization before cell line submission to CCR
|
Species
|
Homo sapiens
|
Common Name
|
Human
|
Remarks
|
|
IDENTIFICATION OF SPECIES OF ORIGIN |
Species of Origin Confirmed by LINE assay |
|
Gene |
OTC |
Chromosomal Location |
Xp21.1 |
Allelic Variant 1 |
; OTC DEFICIENCY |
Identified Mutation |
ARG141TER |
Remarks |
Clinically affected; symptom onset at age 10 years; past hyperammonemic events; normal neurological evulation at age 1 year; heterozygous for a C>T transition at nucleotide 421 in exon 5 of the OTC gene (c.421C>T) resulting in a stop codon at Arg141 [Arg141Ter (R141X)]; treatments include: citrulline arginine supplement, sodium phenylbutyrate, and protein restriction; |
Split Ratio |
1:3 |
Temperature |
37 C |
Percent CO2 |
5% |
Percent O2 |
AMBIENT |
Medium |
Roswell Park Memorial Institute Medium 1640 with 2mM L-glutamine or equivalent |
Serum |
15% fetal bovine serum Not Inactivated |
Substrate |
None specified |
Subcultivation Method |
dilution - add fresh medium |
Supplement |
- |
|
|